ALS Association: Translational Research Advancing Therapy for ALS (TREAT ALS™) / The Lawrence and Isabel Barnett Drug Development Program - BRIDGE GRANTS- Letter of Intent

The Association is requesting letters of intent for its drug development contract program, milestone driven research to develop new treatments for ALS. Priority is given to applications focused on developing compounds directed towards the most attractive targets for ALS with significant data to support the relevance of the chosen target for ALS therapy. Industry partnerships are encouraged. Funding: $200,000 (maximum of 10% indirect costs  allowed) for 2 years.

http://www.alsa.org/research/our-approach/call-for-abstracts/treatals-barnett-bridge-grants.html